A detailed history of Ifp Advisors, Inc transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Ifp Advisors, Inc holds 1,592 shares of AMRN stock, worth $700. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,592
Previous 1,592 -0.0%
Holding current value
$700
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 18, 2023

SELL
$1.19 - $2.19 $10,362 - $19,070
-8,708 Reduced 84.54%
1,592 $2,000
Q4 2022

Feb 07, 2023

BUY
$1.07 - $1.34 $436 - $546
408 Added 4.12%
10,300 $34,000
Q2 2022

Sep 06, 2022

BUY
$1.13 - $3.69 $11,177 - $36,501
9,892 New
9,892 $33,000
Q2 2022

Aug 12, 2022

SELL
$1.13 - $3.69 $11,177 - $36,501
-9,892 Closed
0 $0
Q1 2022

Sep 06, 2022

BUY
$2.85 - $3.73 $23,655 - $30,959
8,300 Added 521.36%
9,892 $32,000
Q3 2020

Oct 29, 2020

BUY
$3.64 - $7.76 $5,794 - $12,353
1,592 New
1,592 $7,000
Q2 2020

Aug 05, 2020

BUY
$4.78 - $8.26 $0 - $0
0 New
0 $0
Q1 2020

May 12, 2020

SELL
$4.0 - $21.53 $8,400 - $45,213
-2,100 Closed
0 $0
Q4 2019

Jan 17, 2020

SELL
$13.94 - $24.12 $102,877 - $178,005
-7,380 Reduced 77.85%
2,100 $45,000
Q3 2019

Nov 07, 2019

BUY
$13.89 - $23.16 $30,099 - $50,187
2,167 Added 29.63%
9,480 $143,000
Q1 2019

May 15, 2019

SELL
$12.61 - $22.33 $13,871 - $24,562
-1,100 Reduced 13.08%
7,313 $152,000
Q4 2018

Jan 23, 2019

BUY
$12.41 - $22.98 $43,435 - $80,430
3,500 Added 71.24%
8,413 $114,000
Q4 2017

Jan 24, 2018

SELL
$3.06 - $4.09 $6,120 - $8,180
-2,000 Reduced 28.93%
4,913 $0
Q3 2017

Oct 30, 2017

SELL
$3.03 - $3.72 $990 - $1,216
-327 Reduced 4.52%
6,913 $24,000
Q2 2017

Jun 03, 2019

BUY
N/A
327 Added 4.73%
7,240 $29,000
Q2 2016

Jun 03, 2019

SELL
N/A
-400 Reduced 5.47%
6,913 $15,000
Q1 2016

Jun 03, 2019

BUY
N/A
7,313
7,313 $152,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Ifp Advisors, Inc Portfolio

Follow Ifp Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.